FT : Julius Baer to withhold millions in bonuses from two former CEOs

Julius Baer to withhold millions in bonuses from two former CEOs
Internal probe penalises Boris Collardi and Bernhard Hodler over money-laundering scandal

Julius Baer will withhold millions of francs in bonuses from its former chief executives Boris Collardi and Bernhard Hodler, as a result of a South American money-laundering scandal dating to their times leading the Swiss wealth manager.

The bank is seeking to withhold more than SFr2.5m ($2.8m) of Mr Collardi’s total deferred pay after an internal probe deemed that he failed properly to oversee the private bank, which has SFr400bn in assets, according to people familiar with the decision.

Mr Collardi left for rival Pictet in 2017 after eight years as chief executive of Julius Baer. The amount to be withheld has not been finalised and is set to include a deferred cash component of about SFr1.3m, the people said.

A spokesman for Mr Collardi confirmed an outstanding deferred cash compensation of about SFr1.3m. The spokesman said Mr Collardi was not aware of any other outstanding deferred compensation due to him by Julius Baer.

Because Mr Collardi left to join a competitor, he had already given up all of his deferred pay in shares. The ultimate forfeit represents only a fraction of his earnings from Julius Baer. For example, he earned SFr6.5m in 2016 alone.


Mr Hodler — the former chief risk officer who succeeded Mr Collardi before himself being replaced last year — is expected to lose a similar amount. The duo’s penalties would have been greater but, owing to company rules, had to be limited to a certain percentage of their pay in specific years, the people added.

“Boris is fighting it . . . more on principle than anything else,” said one source. Another added: “Obviously he is very unhappy and embarrassed about this.”

Mr Collardi and Mr Hodler were not the only senior employees probed over the scandals, which prompted top shareholders to demand the bank withhold pay wherever possible, some of the people familiar with the decisions said.

The leadership of the Latin American business and compliance staff involved were also examined and some of their pay was held back too, albeit on a smaller scale than the top executives, the people added.

A spokeswoman for Julius Baer declined to comment. A spokesman for Pictet declined to comment on Mr Collardi’s behalf. Mr Hodler did not immediately respond to requests for comment.

In February, Julius Baer was sanctioned by Switzerland’s Financial Market Supervisory Authority (Finma) for falling “significantly short” with its anti-money laundering controls between 2009 and 2018, leading to multiple high-profile incidents.

Two years ago, a former Julius Baer banker based in Panama was convicted in a Miami court of helping launder $1.2bn embezzled from Venezuela’s state energy company, Petróleos de Venezuela.

Julius Baer is also in talks with the US Department of Justice to potentially pay tens of millions of dollars to resolve a money laundering and corruption case linked to international football’s governing body, Fifa.

The wealth manager has been banned from making any significant acquisitions until Finma deems its compliance and controls have been improved. The regulator has also said it is examining whether to commence proceedings against any individuals involved, including executives in supervisory positions.

Julius Baer chairman Romeo Lacher said in a letter to shareholders in April that the board was taking “further preventive measures . . . to ensure an appropriate assessment of the impact on the deferred compensation of senior managers earned during the respective years of service” and that some of their actions were “not representative of today’s risk culture”.

During Mr Collardi’s tenure, Julius Baer was at the forefront of a push by Switzerland’s private banks to manage the wealth of the world’s new ultra-rich, embarking on an aggressive and acquisitive expansion across Asia and other emerging markets.

Whilst elevating the company into the top ranks of Swiss wealth managers, the pace of Julius Baer’s growth led to questions about the robustness of its compliance checks on clients’ sources of earnings. It has since closed the offices where the scandals originated, including in Panama, Peru and the Bahamas, and reduced the number of countries in which it operates.

Philipp Rickenbacher, Julius Baer’s current chief executive, has sought to move it on from the damaging regulatory probes and ended its strategy of rapid asset gathering, instead focusing on doing more business with its most profitable existing clients.

FT : Boohoo directors buy in after audit woes flatten shares

Boohoo directors buy in after audit woes flatten shares
Online fashion retailer parts company with PwC

Boohoo directors have swooped in and capitalised on a fall in the fast-fashion retailer’s share price, as the company continues to suffer from fallout related to working practices in its supply chain.

Boohoo said at the start of this week that it was searching for a new auditor as PwC, its auditor since 2014, prepares to end its work for the retailer. Boohoo shares fell by a fifth following its announcement, and remained under pressure as speculation mounted over the identity of PwC’s successor. PwC declined to comment on its motive for ending its relationship with Boohoo.

Boohoo also would not answer questions about a report that suggested it had been rebuffed by a number of major audit firms as part of its search for a replacement. The situation is reminiscent of Frasers’ hunt for an auditor last year, after Grant Thornton decided not to seek re-election for its audit. The retailer was subsequently unable to secure the services of any of the Big Four accounting firms, and officially went without an auditor for a short period. Frasers, then known as Sports Direct, eventually appointed mid-tier auditor RSM.

A spate of director purchases disclosed the day after Boohoo’s audit revelation have helped to steady the share price. Chair Mahmud Kamani has bought £729,210 in shares, taking his position in the company to 12.5 per cent. Deputy chairman Brian Small has bought £25,020 in shares, while Catherine Catto, the wife of chief financial officer Neil Catto, has purchased £14,999 in stock.

The dealings have allowed Mr Kamani in particular to increase his stake in the company at a time of concern over its governance and related share price volatility. Boohoo shares surged in September after it published an independent review into its supply chain failings, but the company must do more to win back the confidence of investors, who have endured a rocky ride of late. Finding an auditor joins revamping the supply chain at the top of Boohoo’s list of priorities.

Judges Scientific focuses on the scientific instruments sector with sales typically driven by long-term growth in higher education. But the group has suffered from the recent Covid-19 disruption to research projects around the world.

Amid the closure of universities, cancellation of scientific conferences and industrial customers trimming their capital expenditure, Judges’ organic revenue shrank by 12 per cent year-on-year in the six months to June 30. Conditions in North America — its second-largest market — were particularly tough, with organic sales dropping by 30 per cent versus a year earlier.

Some resilience to the pandemic turmoil has come from Judges’ “buy-and-build” M&A strategy, with recent acquisitions limiting the overall decline in first-half revenue to 7 per cent. The group purchased Moorfield Nanotechnology — which makes instruments to cover material with thin films — for £2.3m in December and Heath Scientific — which specialises in devices that measure the heat released during chemical reactions — for £7.3m in May.

It has now followed up those two deals with the £2.6m acquisition of Korvus Technology which, like Moorfield, manufactures coating instruments. The majority of Korvus’s sales are to universities and broker Liberum believes it will add a modest £500,000 to Judges’ adjusted operating profit next year.

Against this backdrop, chairman Alex Hambro recently offloaded 2,000 shares worth £103,500. No reason was given for the transaction although Mr Hambro has retained 62,000 shares, equivalent to just under a 1 per cent stake in the company. Judges’ shares are currently sitting slightly above the 5,175p price at which Mr Hambro sold, at 5,200p.

The share disposal was announced hours after news of the Korvus acquisition on October 19. We don’t see the disposal as a red flag, but there is concern over how long it will take Judges’ end markets to recover. It remains unclear when Covid-19 will abate and recessionary conditions will maintain pressure on customers’ capex budgets.

Analysts envisage a slow earnings recovery with consensus forecasts still below pre-pandemic levels in 2022. But the balance sheet is in good trim — the group was sitting on £8.2m of net debt at the end of June, equivalent to just 0.5 times cash profits (Ebitda). This should enable further acquisitions to help bolster growth and Judges has identified more than 2,000 potential targets in the UK alone. It also increased its interim dividend by 10 per cent — a rare feat in the decimated income landscape — suggesting the shares are worth hanging on to.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:

  • LLNW -19.8%, USX -14.1%, EHTH -9.9%, INTC -9.6%, MANH -6.3%, STX -3.5% (also increases dividend and buyback authorization), AXP -2.9%, CYBE -2.3%, RHI -2.3%, ABB -2.1%, BJRI -2%, VNE -1.6%, CLGX -1.5%, CLF -1.5%

Other news:

  • MIST -18.6% (prices underwritten public offering of 3,810,097 of its common shares)
  • WDC -1% (in sympathy with STX earnings)
  • ASR -0.5% (reports Q3 results with traffic down 70.2%)

Analyst comments:

  • FSLY -2.2% (downgraded to Underweight from Neutral at Piper Sandler)
  • CTXS -0.7% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
  • SON -0.6% (downgraded to Neutral from Buy at BofA Securities)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • SAM +8.8%, FFBC +8.3%, MAT +8%, BCS +6.9%, BOOM +6.6%, ABCB +4.8%, COF +4.2%, PKX +3.1%, NXGN +3%, TRTN +3%, VICR +2.3%, PBCT +2%, WAL +1.9%, ASB +1.8%, GBX +1.7%, SIVB +1.4%, ALV +1%

M&A news:

  • CNX +2.1% (EQT may pursue takeover of CNX, according to Bloomberg)
  • PYPL +0.9% (exploring acquisitions of cryptocurrency cos, according to Bloomberg)

Other news:

  • IPHA +11.4% (doses first patient in Monalizumab Phase 3 clinical trial; triggers milestone payment)
  • CVAC +7.6% (announces data from preclinical studies of its investigational SARS-CoV-2 vaccine candidate, CVnCoV, in mice and hamsters)
  • KZR +6% (granted FDA Orphan Drug Designations for KZR-616 for the treatment of polymyositis and dermatomyositis)
  • FUBO +4.9% (fuboTV rolls out updated Multiview feature on Apple TV)
  • GILD +4.5% (confirms FDA approval of remdesivir for the treatment of COVID-19)
  • AUPH +2.8% (announces data from Aurinia's AURA-LV and AURORA pivotal trials)
  • HAS +2.1% (in sympathy with MAT earnings)
  • AKBA +2.1% (presents results from INNO2VATE global Phase 3 program)
  • FTAI +1.4% (to collaborate with LMT on The Module Factory)
  • HHC +1.3% (announces proposal for Lower Manhattan's Seaport area)
  • ZUO +1.2% (Hound Partners increases passive stake)
  • AMD +1.2% (reacting to INTC earnings; INTC struggles favorable for AMD)

Analyst comments:

  • CARG +4.8% (upgraded to Buy from Neutral at BTIG Research)
  • FFIV +4.4% (upgraded to Buy from Neutral at MKM Partners)
  • STNE +2.4% (upgraded to Positive from Neutral at Susquehanna)
  • PHM +1.2% (upgraded to Positive from Neutral at Susquehanna; also upgraded to Outperform from Sector Perform at RBC Capital Mkts)
  • EOG +1% (upgraded to Overweight from Neutral at Piper Sandler)
  • TPH +0.8% (upgraded to Buy from Neutral at B. Riley Securities)

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up:
    • IPHA +11.1%, SAM +8.9%, MAT +8.3%, FFBC +8.3%, BOOM +6.6%, BCS +6.2%, GILD +5.7%, CNX +5%, ABCB +4.8%, COF +3.3%, NXGN +3%, AUPH +2.4%, VICR +2.3%, FUBO +2%, PBCT +2%, PKX +2%, WAL +1.9%, AKBA +1.8%, ASB +1.8%, GBX +1.7%, VLRS +1.6%, FTAI +1.4%, SIVB +1.4%, HHC +1.3%, HAS +1.3%, ZUO +1.2%, AMD +1.1%, PYPL +0.9%
  • Gapping down:
    • MIST -15.9%, USX -14.1%, LLNW -13.2%, EHTH -11.6%, CYBE -11.4%, INTC -9.5%, SFNC -7.9%, MANH -6.3%, ABB -3.4%, STX -2.8%, VRSN -2.8%, RHI -2.3%, BJRI -2%, WDC -1.8%, CLGX -1.5%, LOGI -1.1%

WSJ : Chinese Fintech Company Lufax Seeks Up to $2.4 Billion in U.S. IPO

Chinese Fintech Company Lufax Seeks Up to $2.4 Billion in U.S. IPO
It could potentially be the biggest Chinese IPO in the U.S. since Alibaba’s debut

Lufax Holding Ltd., a smaller rival to Chinese financial-technology giant Ant Group Co., is seeking to raise as much as $2.4 billion from an initial public offering in the U.S.

The deal is likely to put a substantially lower value on Lufax—which has reinvented itself after China cracked down on peer-to-peer lending, once a key business line—than a private fundraising last year.

Lufax, which operates online lending and investment platforms, aims to sell 175 million American depositary shares in a range of $11.50 to $13.50 each, according to a filing Thursday. That implies a market value of $28.1 billion to $32.9 billion, based on the postdeal share count in its listing prospectus.

In early 2019 it was valued at $39.4 billion after raising $1.4 billion of new funds, according to filings by Ping An Insurance (Group) Co., a major shareholder in the company.


Banks underwriting the deal have the option to increase its size by 15%. Depending on where it prices, if the banks exercise that option this could be the biggest Chinese IPO in the U.S. since Alibaba Group Holding Ltd. ’s $25 billion debut in 2014, Dealogic data shows. The next-largest such share sale was by KE Holdings Inc., an online real-estate brokerage that went public in August and raised $2.44 billion.

The stock sale comes as Ant prepares to list in Hong Kong and Shanghai.

Lufax’s targeted valuation reflects heightened volatility in the run-up to the U.S. presidential election on Nov. 3, and its desire to ensure a good secondary-market performance for its shares, a person familiar with the matter said. The deal is likely to price on Oct. 29 and start trading a day later, this person said. Lufax’s stock ticker is LU.

>>> GERMANY OCT PRELIMINARY MANUFACTURING PMI: 58.0 V 55.0E (4th straight expans

GERMANY OCT PRELIMINARY MANUFACTURING PMI: 58.0 V 55.0E (4th straight expansion and highest reading since Apr 2018)
- PMI Services: 48.9 v 49.4e v 50.6 prior (1st contraction in 4 months)
- PMI Composite: 54.5 v 53.3e
- New Orders (Manufacturing): 65.9 v 64.2 Sept final reading (4th month of expansion and record high)
- New Business: 47.8 v 51.3 Sept final reading (1st contraction in 4 months)